Dynamic contrast-enhanced MRI may be helpful to predict response and prognosis after bevacizumab treatment in patients with recurrent high-grade glioma: comparison with diffusion tensor and dynamic susceptibility contrast imaging.
Yae Won ParkSung Soo AhnJu Hyung MoonEui Hyun KimSeok-Gu KangJong Hee ChangSe Hoon KimSeung-Koo LeePublished in: Neuroradiology (2021)
Baseline mean Kep may be a useful biomarker for predicting response and stratifying patient outcomes following bevacizumab treatment in patients with recurrent high-grade glioma.